| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 2 574-581, Copyright © 1996 by American Association of Immunologists
ARTICLES |
RM Gorczynski, Z Cohen, Y Leung and Z Chen
Medical Research Council Transplant Group, Toronto Hospital, Ontario, Canada.
C57BL/6 mice receiving pretransplant immunization with C3H.SW spleen cells via the portal vein, but not the vena cava, show Ag-specific delayed rejection of allogeneic C3H.SW skin grafts. This delayed rejection is not seen if preimmunization is performed in gamma delta TCR knockout (C57BL/6-Tcrdtm1Mom) mice. gamma delta TCR+ and alpha beta TCR+ hybridoma cells were prepared from Peyer's patch cells harvested from C57BL/6 mice 4 days following portal venous immunization with 100 x 10(6) irradiated C3H.SW spleen cells and skin grafting with C3H.SW tail skin. After recloning, these hybridoma cells were tested for cytokine production in vitro following restimulation with irradiated C3H.SW spleen cells and for their ability to delay rejection of C3H.SW skin grafts after adoptive transfer to C57BL/6 mice. Delayed graft rejection was a function of cells that showed preferential production of IL-10, not IFN-gamma, in vitro, independent of the source (vena cava or portal vein immunized mice) or the TCR phenotype of the hybridoma. Simultaneous infusion of anti-IL-10 mAb abolished this graft prolongation effect of transferred gamma delta TCR+ hybridomas. Hybridoma cells producing IL-10 on restimulation could polarize cytokine production from freshly stimulated mesenteric lymph node away from production of IL-2 and IFN-gamma, and toward IL-4, IL-10, and TGF- beta production. This immunoregulation by hybridoma cells in vivo and in vitro was observed even for third party Ag-stimulated mice/cells as long as the hybridoma cells themselves received stimulation with their specific Ag.
This article has been cited by other articles:
|
|
 |
|
  F. Dieli, J. Ivanyi, P. Marsh, A. Williams, I. Naylor, G. Sireci, N. Caccamo, C. Di Sano, and A. Salerno Characterization of Lung {gamma}{delta} T Cells Following Intranasal Infection with Mycobacterium bovis Bacillus Calmette-Guerin J. Immunol., January 1, 2003; 170(1): 463 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xu and J. A. Kapp {gamma}{delta} T Cells in Anterior Chamber-Induced Tolerance in CD8+ CTL Responses Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3473 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Drobyski, S. Vodanovic-Jankovic, and J. Klein Adoptively Transferred {gamma}{delta} T Cells Indirectly Regulate Murine Graft-Versus-Host Reactivity Following Donor Leukocyte Infusion Therapy in Mice J. Immunol., August 1, 2000; 165(3): 1634 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujihashi, T. Dohi, M.-N. Kweon, J. R. Mcghee, T. Koga, M. D. Cooper, S. Tonegawa, and H. Kiyono {gamma}{delta}T cells regulate mucosally induced tolerance in a dose-dependent fashion Int. Immunol., December 1, 1999; 11(12): 1907 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Szalay, C. H. Ladel, C. Blum, L. Brossay, M. Kronenberg, and S. H. E. Kaufmann Cutting Edge: Anti-CD1 Monoclonal Antibody Treatment Reverses the Production Patterns of TGF-{beta}2 and Th1 Cytokines and Ameliorates Listeriosis in Mice J. Immunol., June 15, 1999; 162(12): 6955 - 6958. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
